The Cell Line Development Market is gaining strong momentum, as demand for advanced biopharmaceutical research and therapeutic innovation continues to reshape the global healthcare landscape. According to SNS Insider, the market was valued at USD 5.46 billion in 2023 and is projected to reach USD 12.56 billion by 2032, reflecting a promising compound annual growth rate of 9.66%...